Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Shatha Farhan"'
Autor:
Shatha Farhan, Izabela Mazur, Susan Hartzell, Peter Xie, Klodiana Neme, Angela German, Nancy Mikulandric, Kunj Patel, Min Wu, Neda Kortam, Aseel Yaseen, Aroob Sweidan, Katie Latack, Josephine Emole, Edward Peres, Muneer H. Abidi, Mayur Ramesh
Publikováno v:
International Journal of Infectious Diseases, Vol 147, Iss , Pp 107172- (2024)
Objectives: We aimed to assess whether there is a difference between ciprofloxacin and levofloxacin as prophylaxis in hematopoietic stem cell transplant (SCT) recipients. Methods: This is a prospective, randomized trial in patients receiving SCT at H
Externí odkaz:
https://doaj.org/article/1768ceb83e7443bfa2f5ba6735098b8e
Autor:
Shatha Farhan, Shernan G. Holtan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality after allogeneic stem cell transplantation (SCT). Currently, more patients can receive SCT. This is attributed to the use of reduced intensity regimens and the use of d
Externí odkaz:
https://doaj.org/article/2784da0d9c15442cb5e32c3615c64dbd
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Jan Cerny, Saurabh Chhabra, Zachariah DeFilipp, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Shatha Farhan, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Vikas Gupta, Michael R. Grunwald, Nada Hamad, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Tania Jain, Omer Jamy, Mark Juckett, Matt Kalaycio, Maxwell M. Krem, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Guillermo Ortí, Sagar S. Patel, Marjolein van der Poel, David A. Rizzieri, Bipin N. Savani, Sachiko Seo, Melhem Solh, Leo F. Verdonck, Baldeep Wirk, Jean A. Yared, Ryotaro Nakamura, Betul Oran, Bart Scott, Wael Saber
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment for myelofibrosis. However, the optimal conditioning regimen either with reduced-intensity conditioning (RIC) or myeloablative conditioning (MAC) is not well
Externí odkaz:
https://doaj.org/article/3607fa3e9937487db3f85032af240a0d
Autor:
Shatha Farhan, Michael Bazydlo, Klodiana Neme, Nancy Mikulandric, Edward Peres, Nalini Janakiraman
Publikováno v:
Advances in Hematology, Vol 2017 (2017)
In the era of precision medicine, the impact of personalized dosing of busulfan is not clear. We undertook a retrospective analysis of 78 patients with myeloid malignancies who received fludarabine and busulfan (FluBu4) with or without measuring Bu p
Externí odkaz:
https://doaj.org/article/4ca7eea3ba1149e585821f98e96505bc
Publikováno v:
Advances in Hematology, Vol 2016 (2016)
Allogeneic hematopoietic stem cell transplantation (SCT) is often the only curative option for many patients with malignant and benign hematological stem cell disorders. However, some issues are still of concern regarding finding a donor like shrinki
Externí odkaz:
https://doaj.org/article/d702bb2c749d49f5aa1236f08c695860
Autor:
Dr. Yi-Bin Chen, Shatha Farhan, Lazaros J. Lekakis, Gary J. Schiller, Jean Adel Yared, Amer Assal, Dana D Lee, Hayley Lane, Ted A. Gooley, Zachariah DeFilipp, Dr. Ayman Saad
Publikováno v:
Transplantation and Cellular Therapy. 29:S248-S249
Autor:
Min Wu, Rayli Pichardo, Sowjanya Vuyyala, Josephine Emole, Edward Peres, Muneer H. Abidi, Madhulata Reddy, Shatha Farhan
Publikováno v:
Transplantation and Cellular Therapy. 29:S139-S140
Autor:
Shatha Farhan, Peter Xie, Mrs. Klodiana Neme, Angela German, Nancy Mikulandric, Mrs. Josena Stephen, Mary Ann Trapp, Elizabeth Henne, Sarah Szymanski, Scott Rohrer, Danielle Pelland, Nada Zagar, Izabela Mazur, Nada Rida, Kunj Patel, Min Wu, Neda Kortam, Aseel Yaseen, Aroob Sweidan, Josephine Emole, Edward Peres, Muneer H. Abidi, Mayur Ramesh
Publikováno v:
Transplantation and Cellular Therapy. 29:S319
Autor:
Lawrence S. Lamb, Hemalatha G. Rangarajan, Ran Reshef, Rodrigo Martino, Mahmoud Aljurf, Parinda A. Mehta, Sachiko Seo, Aleksandr Lazaryan, Hisham Abdel-Azim, Miguel Angel Diaz, Vijaya Raj Bhatt, Jean-Yves Cahn, Olle Ringdén, Robert Peter Gale, Jean A. Yared, Shatha Farhan, Usama Gergis, Daniel R. Couriel, Sagar S. Patel, Peiman Hematti, Betty K. Hamilton, Paul Castillo, Mukta Arora, Bipin N. Savani, Lolie C. Yu, Muna Qayed, Leo F. Verdonck, Abraham S. Kanate, Shahinaz M. Gadalla, David Buchbinder, Manish J. Gandhi, Rammurti T. Kamble, Saurabh Chhabra, Mitchell S. Cairo, Tao Wang, Takanori Teshima, Stephen R. Spellman, Kirk R. Schultz, Hadar A. Frangoul, Vaibhav Agrawal, Taiga Nishihori, Yngvar Fløisand, Amer Beitinjaneh, Michael T. Hemmer, Baldeep Wirk, Pooja Khandelwal, Gerhard C. Hildebrandt, Michael Byrne, Shahrukh K. Hashmi, Ravi Vij, Alvaro Urbano-Ispizua, James Gajewski, Richard F. Olsson, Ayman Saad, Joseph Pidala, Harry C. Schouten, Margaret L. MacMillan, Brian C. Shaffer, Basem M. William, Amin M. Alousi, Edmund K. Waller, David I. Marks, Melhem Solh
Publikováno v:
Biology of Blood and Marrow Transplantation, 25(9), 1875-1883. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Data on whether the T cell dose of allogeneic peripheral blood stem cell (PBSC) products influences transplantation outcomes are conflicting. Using the Center for International Blood and Marrow Transplant Research database, we identified 2736 adult p
Autor:
Mohamed A. Kharfan-Dabaja, Leo F. Verdonck, Tania Jain, Gregory A. Hale, Navneet S. Majhail, Baldeep Wirk, Caitrin Fretham, Mahmoud Aljurf, Hemant S. Murthy, Kwang Woo Ahn, Ulrike Bacher, Wael Saber, Bart L. Scott, Jean Yves-Cahn, Daniel J. Weisdorf, Nosha Farhadfar, Richard F. Olsson, Michael R. Grunwald, Amer Beitinjaneh, Bipin N. Savani, Christopher Bredeson, Mark R. Litzow, Shatha Farhan, Jean A. Yared, Sachiko Seo, Jeff Szer, Gerhard C. Hildebrandt, Jan Cerny, David A. Rizzieri, Mitchell Sabloff, Ran Reshef, Vaibhav Agrawal, Robert Peter Gale, Ryotaro Nakamura, Saurabh Chhabra, Attaphol Pawarode, Taiga Nishihori, David I. Marks, Uday R. Popat, Siddhartha Ganguly, Miguel Angel Diaz, Betul Oran, Matt Kalaycio, Edward A. Copelan, Asad Bashey, Hillard M. Lazarus, Jane L. Liesveld, Shahrukh K. Hashmi, Marjolein van der Poel, Sunita Nathan
Publikováno v:
Transplantation and Cellular Therapy, 27(11). Elsevier
Reduced-intensity conditioning (RIC) regimens developed to extend the use of allogeneic hematopoietic stem cell transplantation (HSCT) to older patients have resulted in encouraging outcomes. We aimed to compare the 2 most commonly used RIC regimens,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d6a14a48b561685478be682fe7d726
https://cris.maastrichtuniversity.nl/en/publications/3af6c0ea-79ff-47be-b3cc-a5349bd89b26
https://cris.maastrichtuniversity.nl/en/publications/3af6c0ea-79ff-47be-b3cc-a5349bd89b26